Eurofins performs extensive testing for a variety of drugs, primarily focusing on hazardous compounds for environmental monitoring and safety purposes. Their services encompass a broad spectrum, including specific chemotherapy agents, platinum-based drugs, and hormones.
Comprehensive Drug Testing Capabilities
Eurofins is equipped to test for over 30 different hazardous drugs. This comprehensive testing helps ensure the safety of environments where these potent substances are handled, such as pharmacies, hospitals, and manufacturing facilities, by detecting potential contamination and ensuring compliance with regulatory standards like USP <800>.
Key Categories and Examples of Drugs Tested
Eurofins' testing capabilities cover several critical categories of drugs, many of which are known for their potent therapeutic effects but also require careful handling due to their hazardous nature.
Here's a breakdown of the types of drugs Eurofins tests for:
Drug Category | Specific Examples / Notes |
---|---|
Hazardous Drugs (General) | Over 30 distinct hazardous compounds are routinely tested. |
Antineoplastic Agents | These are chemotherapy drugs, including: |
- 5-fluorouracil | |
- Cyclophosphamide | |
- Doxorubicin | |
- Methotrexate | |
- Paclitaxel | |
Platinum Drugs | This category includes all of the platinum-based chemotherapy drugs (e.g., cisplatin, carboplatin, oxaliplatin). |
Hormones | Various types of hormones are also included in their testing portfolio. |
This testing is crucial for environmental monitoring, helping organizations assess surface contamination in critical areas. By identifying and quantifying these hazardous substances, Eurofins supports clients in maintaining safe working conditions and adhering to stringent health and safety protocols. More information on their environmental monitoring services, particularly for hazardous drugs, can be found on their official site: Eurofins USP 800 Environmental Monitoring.